Biostar Pharmaceuticals, Inc. (BSPM) Research

Biostar Pharmaceuticals, Inc. is a pharmaceutical company based in the People's Republic of China, specializing in the research, manufacturing, and commercialization of both over-the-counter (OTC) and prescription medications designed to treat a wide array of illnesses and health concerns. Its flagship offering is the Xin Ao Xing Oleanolic Acid capsule, an OTC remedy specifically targeting chronic hepatitis B. Beyond this, the company's product line includes twelve additional OTC items and seventeen distinct prescription pharmaceuticals. Among its notable OTC products are the Ganwang compound paracetamol and amantadine hydrochloride capsule, formulated for relieving symptoms of the common cold such as runny nose, sore throat, headache, and fever. It also provides Tianqi Dysmenorrhea capsules, a traditional Chinese medicine used to alleviate menstrual discomfort, and Deafness Tongqiao pills, addressing issues like ear swelling, deafness, tinnitus, and specific internal imbalances. Other OTC solutions include Wenweishu capsules for chronic gastritis, Zhitongtougu ointment for joint pain and inflammation, and Chuzhang Zehaifu tablets for cataracts. The company's prescription-based portfolio features a variety of drugs, including but not limited to Danshen granules, Taohuasan pediatric preparations, Jingang tablets, Danxiang Rhinitis tablets, Yanlixiao capsules, Piracetam tablets, Huangyangning tablets, Hyperthyroidism capsules, Fosfomycin Calcium capsules, Qianlietong capsules, Yituo Erythromycin particles, Danshen tablets, Muxiang Shunqi pills, Sifangwei capsules, and Aspirin Enteric-coated tablets. In a unique initiative, Biostar also operates an online platform known as the China Hepatitis Internet Hospital. This website serves as a valuable resource, offering individuals with Hepatitis B (HBV) comprehensive information about the disease, available treatment options, and a convenient method for purchasing HBV medications. Biostar Pharmaceuticals, Inc. distributes its products nationwide through a robust network of authorized distributors and a dedicated sales force, reaching approximately 28 provinces across China. The company was founded in 2007 and maintains its headquarters in Xianyang, People's Republic of China.

Open Biostar Pharmaceuticals, Inc. (BSPM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.